Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
The Lancet. Rheumatology|January 31, 2024
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trialSatoshi Ebata, Ayumi Yoshizaki, Koji Oba, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2015
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)Masahito Kotaka, Takayuki Yoshino, Koji Oba, et al.
International Journal of Clinical Oncology|October 18, 2015
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study)Chu Matsuda, Michitaka Honda, Chihiro Tanaka, et al.
BMC Cancer|October 27, 2015
Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancerYoshinori Munemoto, Mitsuro Kanda, Keiichiro Ishibashi, et al.
Oncology Letters|March 31, 2017
Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial)Masanori Kotake, Toru Aoyama, Yoshinori Munemoto, et al.
Japanese Journal of Infectious Diseases|July 14, 2015
Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, JapanNobuhisa Ishiguro, Naoko Koseki, Miki Kaiho, et al.
BMC Cancer|May 17, 2023
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trialShinya Abe, Kazushige Kawai, Hiroaki Nozawa, et al.
International Journal of Cancer|June 20, 2022
Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNAJun Watanabe, Hiromichi Maeda, Takeshi Nagasaka, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 27, 2025
Impact of prophylactic antibiotic duration on surgical site infection rate in neonatal surgery: a multicenter retrospective observational studyTomohiro Sunouchi, Jun Fujishiro, Koji Oba, et al.
Journal of Clinical Medicine|December 10, 2021
Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 TrialHironori Ishigami, Yasushi Tsuji, Hisashi Shinohara, et al.
Pageof 24